nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—HTR2A—conduct disorder	0.804	1	CbGaD
Maprotiline—ORM1—saliva—conduct disorder	0.0134	0.245	CbGeAlD
Maprotiline—SLC6A2—autonomic nervous system—conduct disorder	0.0103	0.188	CbGeAlD
Maprotiline—HTR7—autonomic nervous system—conduct disorder	0.00992	0.181	CbGeAlD
Maprotiline—HTR2A—autonomic nervous system—conduct disorder	0.00619	0.113	CbGeAlD
Maprotiline—Sertraline—MAOA—conduct disorder	0.00374	0.341	CrCbGaD
Maprotiline—Sertraline—SLC6A4—conduct disorder	0.00241	0.22	CrCbGaD
Maprotiline—CHRM4—brain—conduct disorder	0.00231	0.0421	CbGeAlD
Maprotiline—CHRM5—brain—conduct disorder	0.0018	0.0329	CbGeAlD
Maprotiline—Protriptyline—SLC6A4—conduct disorder	0.00139	0.126	CrCbGaD
Maprotiline—CHRM2—brain—conduct disorder	0.00124	0.0226	CbGeAlD
Maprotiline—SLC6A3—brain—conduct disorder	0.00123	0.0225	CbGeAlD
Maprotiline—HTR2C—brain—conduct disorder	0.00119	0.0217	CbGeAlD
Maprotiline—CHRM1—brain—conduct disorder	0.00113	0.0205	CbGeAlD
Maprotiline—CHRM3—brain—conduct disorder	0.00101	0.0184	CbGeAlD
Maprotiline—SLC6A2—brain—conduct disorder	0.000995	0.0182	CbGeAlD
Maprotiline—HTR7—brain—conduct disorder	0.000959	0.0175	CbGeAlD
Maprotiline—DRD2—brain—conduct disorder	0.000907	0.0165	CbGeAlD
Maprotiline—HRH1—brain—conduct disorder	0.000716	0.0131	CbGeAlD
Maprotiline—Atomoxetine—SLC6A4—conduct disorder	0.000608	0.0554	CrCbGaD
Maprotiline—HTR2A—brain—conduct disorder	0.000598	0.0109	CbGeAlD
Maprotiline—CYP2D6—brain—conduct disorder	0.000545	0.00994	CbGeAlD
Maprotiline—Nortriptyline—SLC6A4—conduct disorder	0.000531	0.0484	CrCbGaD
Maprotiline—Atomoxetine—HTR2A—conduct disorder	0.000467	0.0425	CrCbGaD
Maprotiline—Desipramine—SLC6A4—conduct disorder	0.000437	0.0398	CrCbGaD
Maprotiline—HTR7—Circadian rythm related genes—DRD4—conduct disorder	0.000425	0.00326	CbGpPWpGaD
Maprotiline—Nortriptyline—HTR2A—conduct disorder	0.000408	0.0372	CrCbGaD
Maprotiline—HTR7—GPCR ligand binding—CGA—conduct disorder	0.000405	0.00311	CbGpPWpGaD
Maprotiline—HTR2C—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000393	0.00302	CbGpPWpGaD
Maprotiline—ABCB1—brain—conduct disorder	0.000392	0.00715	CbGeAlD
Maprotiline—CHRM4—GPCR ligand binding—CGA—conduct disorder	0.000383	0.00294	CbGpPWpGaD
Maprotiline—Imipramine—SLC6A4—conduct disorder	0.000371	0.0338	CrCbGaD
Maprotiline—CHRM5—GPCR ligand binding—CGA—conduct disorder	0.000367	0.00282	CbGpPWpGaD
Maprotiline—HTR2A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000354	0.00272	CbGpPWpGaD
Maprotiline—CHRM4—G alpha (i) signalling events—DRD4—conduct disorder	0.000354	0.00272	CbGpPWpGaD
Maprotiline—HTR7—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000348	0.00267	CbGpPWpGaD
Maprotiline—CHRM2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000348	0.00267	CbGpPWpGaD
Maprotiline—DRD2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000346	0.00266	CbGpPWpGaD
Maprotiline—HTR2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000341	0.00262	CbGpPWpGaD
Maprotiline—HRH1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00034	0.00261	CbGpPWpGaD
Maprotiline—CHRM1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000339	0.0026	CbGpPWpGaD
Maprotiline—CHRM3—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000338	0.0026	CbGpPWpGaD
Maprotiline—Desipramine—HTR2A—conduct disorder	0.000336	0.0306	CrCbGaD
Maprotiline—CHRM2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000335	0.00257	CbGpPWpGaD
Maprotiline—CHRM3—GPCRs, Other—HTR2A—conduct disorder	0.000332	0.00255	CbGpPWpGaD
Maprotiline—CHRM4—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000329	0.00252	CbGpPWpGaD
Maprotiline—CHRM2—GPCRs, Other—HTR2A—conduct disorder	0.000329	0.00252	CbGpPWpGaD
Maprotiline—CHRM5—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000315	0.00242	CbGpPWpGaD
Maprotiline—HTR2C—GPCR ligand binding—CGA—conduct disorder	0.000299	0.0023	CbGpPWpGaD
Maprotiline—HTR7—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000298	0.00229	CbGpPWpGaD
Maprotiline—DRD2—Circadian rythm related genes—SLC6A4—conduct disorder	0.000294	0.00226	CbGpPWpGaD
Maprotiline—CHRM1—Circadian rythm related genes—SLC6A4—conduct disorder	0.000288	0.00221	CbGpPWpGaD
Maprotiline—Imipramine—HTR2A—conduct disorder	0.000285	0.026	CrCbGaD
Maprotiline—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000282	0.00216	CbGpPWpGaD
Maprotiline—SLC6A3—Transmission across Chemical Synapses—COMT—conduct disorder	0.000279	0.00214	CbGpPWpGaD
Maprotiline—SLC6A3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000277	0.00213	CbGpPWpGaD
Maprotiline—DRD2—Circadian rythm related genes—DRD4—conduct disorder	0.000276	0.00212	CbGpPWpGaD
Maprotiline—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000275	0.00211	CbGpPWpGaD
Maprotiline—CHRM1—Circadian rythm related genes—DRD4—conduct disorder	0.000271	0.00208	CbGpPWpGaD
Maprotiline—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00027	0.00207	CbGpPWpGaD
Maprotiline—SLC6A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000269	0.00207	CbGpPWpGaD
Maprotiline—HRH1—IL-4 Signaling Pathway—EP300—conduct disorder	0.000269	0.00206	CbGpPWpGaD
Maprotiline—HTR2A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000267	0.00205	CbGpPWpGaD
Maprotiline—CHRM5—G alpha (q) signalling events—HTR2A—conduct disorder	0.000266	0.00204	CbGpPWpGaD
Maprotiline—DRD2—GPCR ligand binding—CGA—conduct disorder	0.000264	0.00203	CbGpPWpGaD
Maprotiline—CHRM2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000262	0.00201	CbGpPWpGaD
Maprotiline—HTR2A—GPCR ligand binding—CGA—conduct disorder	0.00026	0.00199	CbGpPWpGaD
Maprotiline—HRH1—GPCR ligand binding—CGA—conduct disorder	0.000259	0.00199	CbGpPWpGaD
Maprotiline—CHRM1—GPCR ligand binding—CGA—conduct disorder	0.000258	0.00198	CbGpPWpGaD
Maprotiline—CHRM3—GPCR ligand binding—CGA—conduct disorder	0.000257	0.00198	CbGpPWpGaD
Maprotiline—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000257	0.00197	CbGpPWpGaD
Maprotiline—CHRM2—GPCR ligand binding—CGA—conduct disorder	0.000255	0.00196	CbGpPWpGaD
Maprotiline—DRD2—G alpha (i) signalling events—DRD4—conduct disorder	0.000244	0.00187	CbGpPWpGaD
Maprotiline—SLC6A3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000238	0.00183	CbGpPWpGaD
Maprotiline—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000238	0.00183	CbGpPWpGaD
Maprotiline—CHRM2—G alpha (i) signalling events—DRD4—conduct disorder	0.000236	0.00181	CbGpPWpGaD
Maprotiline—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000233	0.00179	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—CGA—conduct disorder	0.000229	0.00176	CbGpPWpGaD
Maprotiline—HTR7—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000227	0.00174	CbGpPWpGaD
Maprotiline—HTR7—GPCR ligand binding—DRD4—conduct disorder	0.000227	0.00174	CbGpPWpGaD
Maprotiline—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000226	0.00174	CbGpPWpGaD
Maprotiline—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000223	0.00171	CbGpPWpGaD
Maprotiline—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000222	0.00171	CbGpPWpGaD
Maprotiline—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000222	0.0017	CbGpPWpGaD
Maprotiline—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000221	0.0017	CbGpPWpGaD
Maprotiline—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00022	0.00169	CbGpPWpGaD
Maprotiline—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000219	0.00168	CbGpPWpGaD
Maprotiline—HTR2C—G alpha (q) signalling events—HTR2A—conduct disorder	0.000217	0.00166	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—CGA—conduct disorder	0.000216	0.00166	CbGpPWpGaD
Maprotiline—CHRM4—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000214	0.00165	CbGpPWpGaD
Maprotiline—CHRM4—GPCR ligand binding—DRD4—conduct disorder	0.000214	0.00165	CbGpPWpGaD
Maprotiline—SLC6A3—Neuronal System—COMT—conduct disorder	0.000213	0.00164	CbGpPWpGaD
Maprotiline—CHRM2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000213	0.00164	CbGpPWpGaD
Maprotiline—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.000213	0.00164	CbGpPWpGaD
Maprotiline—SLC6A3—Neuronal System—MAOA—conduct disorder	0.000212	0.00163	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—CGA—conduct disorder	0.000208	0.0016	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—CGA—conduct disorder	0.000207	0.00159	CbGpPWpGaD
Maprotiline—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000205	0.00158	CbGpPWpGaD
Maprotiline—CHRM5—GPCR ligand binding—DRD4—conduct disorder	0.000205	0.00158	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—CGA—conduct disorder	0.000196	0.00151	CbGpPWpGaD
Maprotiline—HTR7—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000195	0.00149	CbGpPWpGaD
Maprotiline—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000194	0.00149	CbGpPWpGaD
Maprotiline—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000194	0.00149	CbGpPWpGaD
Maprotiline—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000191	0.00147	CbGpPWpGaD
Maprotiline—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00019	0.00146	CbGpPWpGaD
Maprotiline—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00019	0.00146	CbGpPWpGaD
Maprotiline—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000189	0.00145	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—CGA—conduct disorder	0.000188	0.00145	CbGpPWpGaD
Maprotiline—HRH1—G alpha (q) signalling events—HTR2A—conduct disorder	0.000188	0.00144	CbGpPWpGaD
Maprotiline—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000187	0.00144	CbGpPWpGaD
Maprotiline—CHRM1—G alpha (q) signalling events—HTR2A—conduct disorder	0.000187	0.00144	CbGpPWpGaD
Maprotiline—CHRM3—G alpha (q) signalling events—HTR2A—conduct disorder	0.000186	0.00143	CbGpPWpGaD
Maprotiline—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000184	0.00141	CbGpPWpGaD
Maprotiline—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000176	0.00135	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—CGA—conduct disorder	0.000169	0.0013	CbGpPWpGaD
Maprotiline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000168	0.00129	CbGpPWpGaD
Maprotiline—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000167	0.00129	CbGpPWpGaD
Maprotiline—HTR2C—GPCR ligand binding—DRD4—conduct disorder	0.000167	0.00129	CbGpPWpGaD
Maprotiline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000167	0.00129	CbGpPWpGaD
Maprotiline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000167	0.00128	CbGpPWpGaD
Maprotiline—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.000154	0.00118	CbGpPWpGaD
Maprotiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.000154	0.00118	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—CGA—conduct disorder	0.000153	0.00118	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.000149	0.00115	CbGpPWpGaD
Maprotiline—HTR7—GPCR ligand binding—HTR2A—conduct disorder	0.000148	0.00114	CbGpPWpGaD
Maprotiline—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000148	0.00114	CbGpPWpGaD
Maprotiline—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.000148	0.00113	CbGpPWpGaD
Maprotiline—CYP2D6—Biological oxidations—COMT—conduct disorder	0.000147	0.00113	CbGpPWpGaD
Maprotiline—HTR7—Circadian rythm related genes—EP300—conduct disorder	0.000147	0.00113	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—CGA—conduct disorder	0.000147	0.00113	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—CGA—conduct disorder	0.000146	0.00112	CbGpPWpGaD
Maprotiline—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.000146	0.00112	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—CGA—conduct disorder	0.000146	0.00112	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—CGA—conduct disorder	0.000145	0.00112	CbGpPWpGaD
Maprotiline—HTR2A—GPCR ligand binding—DRD4—conduct disorder	0.000145	0.00112	CbGpPWpGaD
Maprotiline—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.000145	0.00112	CbGpPWpGaD
Maprotiline—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000145	0.00111	CbGpPWpGaD
Maprotiline—HRH1—GPCR ligand binding—DRD4—conduct disorder	0.000145	0.00111	CbGpPWpGaD
Maprotiline—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000145	0.00111	CbGpPWpGaD
Maprotiline—CHRM1—GPCR ligand binding—DRD4—conduct disorder	0.000145	0.00111	CbGpPWpGaD
Maprotiline—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.000144	0.00111	CbGpPWpGaD
Maprotiline—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000144	0.00111	CbGpPWpGaD
Maprotiline—CHRM3—GPCR ligand binding—DRD4—conduct disorder	0.000144	0.00111	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—CGA—conduct disorder	0.000144	0.00111	CbGpPWpGaD
Maprotiline—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000143	0.0011	CbGpPWpGaD
Maprotiline—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000143	0.0011	CbGpPWpGaD
Maprotiline—CHRM2—GPCR ligand binding—DRD4—conduct disorder	0.000143	0.0011	CbGpPWpGaD
Maprotiline—CHRM4—GPCR ligand binding—HTR2A—conduct disorder	0.00014	0.00107	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—CGA—conduct disorder	0.000135	0.00104	CbGpPWpGaD
Maprotiline—CHRM5—GPCR ligand binding—HTR2A—conduct disorder	0.000134	0.00103	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—CGA—conduct disorder	0.000133	0.00102	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—CGA—conduct disorder	0.000133	0.00102	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—CGA—conduct disorder	0.000132	0.00102	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—CGA—conduct disorder	0.000132	0.00101	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—CGA—conduct disorder	0.000131	0.001	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—DRD4—conduct disorder	0.000128	0.000986	CbGpPWpGaD
Maprotiline—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000127	0.000972	CbGpPWpGaD
Maprotiline—CYP1A2—Biological oxidations—COMT—conduct disorder	0.000125	0.000958	CbGpPWpGaD
Maprotiline—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000124	0.000955	CbGpPWpGaD
Maprotiline—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000124	0.000952	CbGpPWpGaD
Maprotiline—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.000124	0.000952	CbGpPWpGaD
Maprotiline—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000123	0.000949	CbGpPWpGaD
Maprotiline—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.000123	0.000945	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CGA—conduct disorder	0.000123	0.000944	CbGpPWpGaD
Maprotiline—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000122	0.000939	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—DRD4—conduct disorder	0.000121	0.000931	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000119	0.000911	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—DRD4—conduct disorder	0.000117	0.000895	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CGA—conduct disorder	0.000116	0.000892	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—DRD4—conduct disorder	0.000116	0.000892	CbGpPWpGaD
Maprotiline—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000115	0.000885	CbGpPWpGaD
Maprotiline—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000113	0.000869	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CGA—conduct disorder	0.000111	0.000854	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—DRD4—conduct disorder	0.00011	0.000845	CbGpPWpGaD
Maprotiline—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	0.000109	0.000839	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000106	0.000815	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—DRD4—conduct disorder	0.000105	0.00081	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—WASF1—conduct disorder	9.85e-05	0.000757	CbGpPWpGaD
Maprotiline—DRD2—GPCR ligand binding—HTR2A—conduct disorder	9.64e-05	0.000741	CbGpPWpGaD
Maprotiline—DRD2—Circadian rythm related genes—EP300—conduct disorder	9.56e-05	0.000734	CbGpPWpGaD
Maprotiline—HRH1—GPCR ligand binding—HTR2A—conduct disorder	9.46e-05	0.000727	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	9.46e-05	0.000727	CbGpPWpGaD
Maprotiline—CHRM1—GPCR ligand binding—HTR2A—conduct disorder	9.43e-05	0.000725	CbGpPWpGaD
Maprotiline—CHRM3—GPCR ligand binding—HTR2A—conduct disorder	9.4e-05	0.000722	CbGpPWpGaD
Maprotiline—CHRM1—Circadian rythm related genes—EP300—conduct disorder	9.35e-05	0.000719	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—CGA—conduct disorder	9.33e-05	0.000717	CbGpPWpGaD
Maprotiline—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	9.31e-05	0.000715	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—WASF1—conduct disorder	9.3e-05	0.000715	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CGA—conduct disorder	9.06e-05	0.000696	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—WASF1—conduct disorder	8.91e-05	0.000684	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—DRD4—conduct disorder	8.59e-05	0.00066	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—HTR2A—conduct disorder	8.37e-05	0.000643	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—DRD4—conduct disorder	8.35e-05	0.000641	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	8.21e-05	0.000631	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—DRD4—conduct disorder	8.2e-05	0.00063	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—DRD4—conduct disorder	8.17e-05	0.000628	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—DRD4—conduct disorder	8.14e-05	0.000626	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	8.07e-05	0.00062	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CGA—conduct disorder	8e-05	0.000614	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—HTR2A—conduct disorder	7.91e-05	0.000607	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CGA—conduct disorder	7.87e-05	0.000605	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CGA—conduct disorder	7.85e-05	0.000603	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CGA—conduct disorder	7.83e-05	0.000601	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CGA—conduct disorder	7.8e-05	0.000599	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CGA—conduct disorder	7.73e-05	0.000594	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—HTR2A—conduct disorder	7.6e-05	0.000584	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—DRD4—conduct disorder	7.58e-05	0.000582	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—HTR2A—conduct disorder	7.57e-05	0.000582	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—DRD4—conduct disorder	7.46e-05	0.000573	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—DRD4—conduct disorder	7.44e-05	0.000572	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—DRD4—conduct disorder	7.42e-05	0.00057	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—DRD4—conduct disorder	7.4e-05	0.000568	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—DRD4—conduct disorder	7.32e-05	0.000563	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—WASF1—conduct disorder	7.26e-05	0.000558	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—HTR2A—conduct disorder	7.18e-05	0.000552	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—DRD4—conduct disorder	6.88e-05	0.000529	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—HTR2A—conduct disorder	6.88e-05	0.000528	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—DRD4—conduct disorder	6.5e-05	0.000499	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—WASF1—conduct disorder	6.41e-05	0.000492	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—WASF1—conduct disorder	6.31e-05	0.000484	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—WASF1—conduct disorder	6.29e-05	0.000483	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—WASF1—conduct disorder	6.27e-05	0.000482	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—WASF1—conduct disorder	6.25e-05	0.00048	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—DRD4—conduct disorder	6.23e-05	0.000478	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—WASF1—conduct disorder	6.19e-05	0.000476	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	6.17e-05	0.000474	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	6.16e-05	0.000473	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CGA—conduct disorder	5.92e-05	0.000455	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	5.6e-05	0.000431	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CGA—conduct disorder	5.58e-05	0.000429	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	5.45e-05	0.000418	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	5.35e-05	0.000411	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—HTR2A—conduct disorder	5.33e-05	0.00041	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—HTR2A—conduct disorder	5.31e-05	0.000408	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	5.26e-05	0.000404	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—DRD4—conduct disorder	5.07e-05	0.00039	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—HTR2A—conduct disorder	4.95e-05	0.00038	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—HTR2A—conduct disorder	4.86e-05	0.000373	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—HTR2A—conduct disorder	4.84e-05	0.000372	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—HTR2A—conduct disorder	4.83e-05	0.000371	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	4.78e-05	0.000367	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CGA—conduct disorder	4.73e-05	0.000363	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—HTR2A—conduct disorder	4.49e-05	0.000345	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—DRD4—conduct disorder	4.48e-05	0.000344	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—DRD4—conduct disorder	4.41e-05	0.000339	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—DRD4—conduct disorder	4.4e-05	0.000338	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—DRD4—conduct disorder	4.38e-05	0.000337	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—DRD4—conduct disorder	4.37e-05	0.000336	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—DRD4—conduct disorder	4.33e-05	0.000332	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—HTR2A—conduct disorder	4.24e-05	0.000326	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—COMT—conduct disorder	4.21e-05	0.000324	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—MAOA—conduct disorder	4.18e-05	0.000321	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—HTR2A—conduct disorder	4.06e-05	0.000312	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—HTR2A—conduct disorder	3.31e-05	0.000254	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—HTR2A—conduct disorder	2.92e-05	0.000224	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—HTR2A—conduct disorder	2.87e-05	0.00022	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—HTR2A—conduct disorder	2.86e-05	0.00022	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—HTR2A—conduct disorder	2.85e-05	0.000219	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—HTR2A—conduct disorder	2.82e-05	0.000217	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—COMT—conduct disorder	2.67e-05	0.000205	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—MAOA—conduct disorder	2.65e-05	0.000204	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—COMT—conduct disorder	2.52e-05	0.000193	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—MAOA—conduct disorder	2.5e-05	0.000192	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—EP300—conduct disorder	2.38e-05	0.000183	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—EP300—conduct disorder	2.25e-05	0.000173	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—EP300—conduct disorder	2.15e-05	0.000165	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—COMT—conduct disorder	2.13e-05	0.000164	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—MAOA—conduct disorder	2.12e-05	0.000163	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	2.05e-05	0.000158	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—EP300—conduct disorder	1.81e-05	0.000139	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—EP300—conduct disorder	1.75e-05	0.000135	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—EP300—conduct disorder	1.55e-05	0.000119	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—EP300—conduct disorder	1.52e-05	0.000117	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—EP300—conduct disorder	1.52e-05	0.000117	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—EP300—conduct disorder	1.52e-05	0.000116	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—EP300—conduct disorder	1.51e-05	0.000116	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—EP300—conduct disorder	1.5e-05	0.000115	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—EP300—conduct disorder	1.15e-05	8.8e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—EP300—conduct disorder	1.08e-05	8.3e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—EP300—conduct disorder	9.15e-06	7.03e-05	CbGpPWpGaD
